flow trial glp 1 Glucagon-Like Peptide-1 (GLP-1)-Based Therapies and Heart Failure Outcomes: A Scoping Review of Contemporary Randomized Controlled Trials New trial on miracle GLP-1

in terms of safety, tolerability and immunogenicity

GLP-1 receptor agonists have exploded in popularity, with prescriptions increasing by 364 percent between 2019 and 2024

When used under the care of Dr Sultan, this therapy becomes part of a larger wellness strategy that builds a healthier future, not just a smaller number on a scale

Surgical colectomy becomes necessary in approximately 10-15% of patients with contemporary medical therapy, though rates vary by disease severity and treatment era

The reviewed papers focused on different populations: the most represented populations where those of healthy participants (14 studies) and individuals with overweight and obesity (13 studies)